VIDEO: Acorda Therapeutics, Inc. (ACOR)

Acorda Therapeutics, Inc., a biopharmaceutical company, identifies, develops, and commercializes novel therapies for neurological disorders in the United States. The company markets Ampyra (dalfampridine), a potassium channel blocker to improve walking in patients with multiple sclerosis (MS); Zanaflex Capsules and Zanaflex tablets for the management of spasticity, a symptom of central nervous system disorders; and Qutenza, a dermal patch for the management of neuropathic pain associated with post-herpetic neuralgia.


The company also markets Ampyra as Fampyra in Europe, Asia, and the Americas. It is also involved in developing CVT-301, which is in Phase III clinical trial for the treatment of OFF episodes in ParkinsonÂ’s disease; Dalfampridine that is in Phase III clinical trial for the treatment of chronic post-stroke deficits; Neuregulin Program, which is in Phase Ib clinical trial for the treatment of heart failure; CVT-427 that is in pre-clinical development for the treatment of migraines; Remyelinating Antibodies Program, which is in Phase I clinical trial for the treatment of MS; and Chondroitinase Program that is in research stage for the treatment of spinal cord injury, as well as developing Plumiaz, a proprietary nasal spray formulation of diazepam for the treatment of people with epilepsy. The company has a collaboration agreement with Biogen Idec International GmbH for the development and commercialization of products containing aminopyridines. The company was founded in 1995 and is headquartered in Ardsley, New York.

BLOG COMMENTS POWERED BY DISQUS

Get the Latest Videos

Small Cap Movers

Comstock Resources, Inc. Common

NYQ : CRK - 05 Feb, 11:48am
1.385
+0.105 (+8.203%) After Hours:
Open 1.220 Mktcap 66.09M
High 1.510 52wk Hight 6.840
Low 1.200 52wk Low 0.970
Vol 975567 Avg Vol 1.21M
Eps -4.600 P/e
Currency: USD

Argos Therapeutics, Inc.

NGM : ARGS - 05 Feb, 11:46am
3.03
-0.02 (-0.66%) After Hours:
Open 3.07 Mktcap 62.83M
High 3.15 52wk Hight 9.64
Low 3.00 52wk Low 1.61
Vol 25879 Avg Vol 106258
Eps -3.58 P/e
Currency: USD

Amyris, Inc.

NMS : AMRS - 05 Feb, 11:44am
1.45
+0.00 (+0.00%) After Hours:
Open 1.46 Mktcap 278.65M
High 1.49 52wk Hight 3.11
Low 1.44 52wk Low 1.13
Vol 6767 Avg Vol 156437
Eps -1.70 P/e
Currency: USD

Alliance Holdings GP, L.P.

NMS : AHGP - 05 Feb, 11:47am
18.09
-0.02 (-0.11%) After Hours:
Open 18.01 Mktcap 1.08B
High 18.37 52wk Hight 57.37
Low 17.45 52wk Low 12.43
Vol 48565 Avg Vol 169381
Eps 3.11 P/e 5.12
Currency: USD
×

Sign Up For Our Newsletter